Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP274565C

TPD52L3/D55 Antibody (OTI6E1), DyLight 650, Novus Biologicals™
SDP

Catalog No. NBP274565C Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP274565C 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP274565C Supplier Novus Biologicals Supplier No. NBP274565C
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

TPD52L3/D55 Monoclonal specifically detects TPD52L3/D55 in Human samples. It is validated for Western Blot.

Specifications

Antigen TPD52L3/D55
Applications Western Blot
Classification Monoclonal
Clone OTI6E1
Conjugate DyLight 650
Dilution Western Blot
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias hD55, MGC26757, NYDSP25, NYD-SP25, protein kinase NYD-SP25, Testis development protein NYD-SP25, tumor protein D52-like 3MGC45374, tumor protein D55
Gene Symbols TPD52L3
Host Species Mouse
Immunogen Full length recombinant protein of human TPD52L3/D55 (NP_001001875) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Research Discipline Protein Kinase
Primary or Secondary Primary
Gene ID (Entrez) 89882.0
Target Species Human
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.